3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
21
Lymphoma, Mantle-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
10
Waldenstrom Macroglobulinemia
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Neoplasms
4
Leukemia, B-Cell
4
Lymphoma, B-Cell
3
Burkitt Lymphoma
3
Recurrence
2
Leukemia, Prolymphocytic
2
Leukemia, Lymphoid
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Diseases
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, AIDS-Related
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic, B-Cell
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Sunitinib
2
Everolimus
2
sargramostim
1
montanide ISA 51
1
lutetium Lu 177 dotatate
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
X-Rays
1
Temozolomide
1
Phantoms, Imaging
1
Octreotide
1
Methods
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
ibrutinib
×
90 days
×
Clear all
No trials found.